← Open Payments lookup

EUGENE OTCHERE: Open Payments

NPI 1659048486 · CRANFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$864 in 50 payments from 10 companies in 2025. Trend: 2023 $957 · 2024 $916 · 2025 $864

Food & beverage: $864
CompanyPaymentsAmount
ABBVIE INC.26$381
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$207
Neurocrine BioSciences, Inc.5$88
Axsome Therapeutics, Inc.4$64
Otsuka America Pharmaceutical, Inc.2$32
Janssen Pharmaceuticals, Inc1$22
Teva Pharmaceuticals USA, Inc.1$19
Alkermes, Inc.1$18
E.R. Squibb & Sons, L.L.C.1$17
Tris Pharma Inc1$17

Products named: VRAYLAR, CAPLYTA, INGREZZA, Sunosi, REXULTI, SPRAVATO, AUSTEDO XR, ARISTADA.

Industry payments across NJ — which companies pay providers there.